This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Smith, J. L.
Right arrow Articles by Ostrowski, M. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Smith, J. L.
Right arrow Articles by Ostrowski, M. C.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, November 2000, p. 8026-8034, Vol. 20, No. 21
0270-7306/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

ets-2 Is a Target for an Akt (Protein Kinase B)/Jun N-Terminal Kinase Signaling Pathway in Macrophages of motheaten-viable Mutant Mice

James L. Smith,1 Alicia E. Schaffner,1 Joseph K. Hofmeister,1,2 Matthew Hartman,1 Guo Wei,1 David Forsthoefel,1 David A. Hume,3 and Michael C. Ostrowski1,*

Department of Molecular Genetics and the Comprehensive Cancer Center1 and Division of Hematology & Oncology,2 Ohio State University, Columbus, Ohio 43210, and Departments of Biochemistry and Microbiology and Centre for Molecular and Cellular Biology, University of Queensland, Brisbane, Australia3

Received 20 March 2000/Returned for modification 4 May 2000/Accepted 8 August 2000

The transcription factor ets-2 was phosphorylated at residue threonine 72 in a colony-stimulating factor 1 (CSF-1)- and mitogen-activated protein kinase-independent manner in macrophages isolated from motheaten-viable (me-v) mice. The CSF-1 and ets-2 target genes coding for Bcl-x, urokinase plasminogen activator, and scavenger receptor were also expressed at high levels independent of CSF-1 addition to me-v cells. Akt (protein kinase B) was constitutively active in me-v macrophages, and an Akt immunoprecipitate catalyzed phosphorylation of ets-2 at threonine 72. The p54 isoform of c-jun N-terminal kinase-stress-activated kinase (JNK- SAPK) coimmunoprecipitated with Akt from me-v macrophages, and treatment of me-v cells with the specific phosphatidylinositol 3-kinase inhibitor LY294002 decreased cell survival, Akt and JNK kinase activities, ets-2 phosphorylation, and Bcl-x mRNA expression. Therefore, ets-2 is a target for phosphatidylinositol 3-kinase-Akt-JNK action, and the JNK p54 isoform is an ets-2 kinase in macrophages. Constitutive ets-2 activity may contribute to the pathology of me-v mice by increasing expression of genes like the Bcl-x gene that promote macrophage survival.


* Corresponding author. Mailing address: Department of Molecular Genetics, Ohio State University, 484 W. 12th Ave., Columbus, OH 43210. Phone: (614) 688-3824. Fax: (614) 688-8727. E-mail: ostrowski.4{at}osu.edu.


Molecular and Cellular Biology, November 2000, p. 8026-8034, Vol. 20, No. 21
0270-7306/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Sester, D. P., Brion, K., Trieu, A., Goodridge, H. S., Roberts, T. L., Dunn, J., Hume, D. A., Stacey, K. J., Sweet, M. J. (2006). CpG DNA Activates Survival in Murine Macrophages through TLR9 and the Phosphatidylinositol 3-Kinase-Akt Pathway. J. Immunol. 177: 4473-4480 [Abstract] [Full Text]  
  • Irvine, K. M., Burns, C. J., Wilks, A. F., Su, S., Hume, D. A., Sweet, M. J. (2006). A CSF-1 receptor kinase inhibitor targets effector functions and inhibits pro-inflammatory cytokine production from murine macrophage populations. FASEB J. 20: 1921-1923 [Abstract] [Full Text]  
  • Himes, S. R., Sester, D. P., Ravasi, T., Cronau, S. L., Sasmono, T., Hume, D. A. (2006). The JNK Are Important for Development and Survival of Macrophages. J. Immunol. 176: 2219-2228 [Abstract] [Full Text]  
  • Myers, E., Hill, A. D.K., Kelly, G., McDermott, E. W., O'Higgins, N. J., Buggy, Y., Young, L. S. (2005). Associations and Interactions between Ets-1 and Ets-2 and Coregulatory Proteins, SRC-1, AIB1, and NCoR in Breast Cancer. Clin. Cancer Res. 11: 2111-2122 [Abstract] [Full Text]  
  • Chung, S. W., Chen, Y.-H., Perrella, M. A. (2005). Role of Ets-2 in the Regulation of Heme Oxygenase-1 by Endotoxin. J. Biol. Chem. 280: 4578-4584 [Abstract] [Full Text]  
  • Ezashi, T., Roberts, R. M. (2004). Regulation of Interferon-{tau} (IFN-{tau}) Gene Promoters by Growth Factors that Target the Ets-2 Composite Enhancer: A Possible Model for Maternal Control of IFN-{tau} Production by the Conceptus during Early Pregnancy. Endocrinology 145: 4452-4460 [Abstract] [Full Text]  
  • Wei, G., Guo, J., Doseff, A. I., Kusewitt, D. F., Man, A. K., Oshima, R. G., Ostrowski, M. C. (2004). Activated Ets2 Is Required for Persistent Inflammatory Responses in the Motheaten Viable Model. J. Immunol. 173: 1374-1379 [Abstract] [Full Text]  
  • Matsuda, S., Harries, J. C., Viskaduraki, M., Troke, P. J. F., Kindle, K. B., Ryan, C., Heery, D. M. (2004). A Conserved {alpha}-Helical Motif Mediates the Binding of Diverse Nuclear Proteins to the SRC1 Interaction Domain of CBP. J. Biol. Chem. 279: 14055-14064 [Abstract] [Full Text]  
  • Man, A. K., Young, L. J. T., Tynan, J. A., Lesperance, J., Egeblad, M., Werb, Z., Hauser, C. A., Muller, W. J., Cardiff, R. D., Oshima, R. G. (2003). Ets2-Dependent Stromal Regulation of Mouse Mammary Tumors. Mol. Cell. Biol. 23: 8614-8625 [Abstract] [Full Text]  
  • Baker, K. M., Wei, G., Schaffner, A. E., Ostrowski, M. C. (2003). Ets-2 and Components of Mammalian SWI/SNF Form a Repressor Complex That Negatively Regulates the BRCA1 Promoter. J. Biol. Chem. 278: 17876-17884 [Abstract] [Full Text]  
  • Weng, L.-P., Brown, J. L., Baker, K. M., Ostrowski, M. C., Eng, C. (2002). PTEN blocks insulin-mediated ETS-2 phosphorylation through MAP kinase, independently of the phosphoinositide 3-kinase pathway. Hum Mol Genet 11: 1687-1696 [Abstract] [Full Text]  
  • Duval, D. L., Gutierrez-Hartmann, A. (2002). Editorial: PRL-Releasing Peptide Stimulation of PRL Gene Transcription--Enter AKT. Endocrinology 143: 11-12 [Full Text]  
  • Hayakawa, J., Ohmichi, M., Tasaka, K., Kanda, Y., Adachi, K., Nishio, Y., Hisamoto, K., Mabuchi, S., Hinuma, S., Murata, Y. (2002). Regulation of the PRL Promoter by Akt through cAMP Response Element Binding Protein. Endocrinology 143: 13-22 [Abstract] [Full Text]  
  • Seidel, J. J., Graves, B. J. (2002). An ERK2 docking site in the Pointed domain distinguishes a subset of ETS transcription factors. Genes Dev. 16: 127-137 [Abstract] [Full Text]  
  • Matsuguchi, T., Musikacharoen, T., Johnson, T. R., Kraft, A. S., Yoshikai, Y. (2001). A Novel Mitogen-Activated Protein Kinase Phosphatase Is an Important Negative Regulator of Lipopolysaccharide-Mediated c-Jun N-Terminal Kinase Activation in Mouse Macrophage Cell Lines. Mol. Cell. Biol. 21: 6999-7009 [Abstract] [Full Text]  
  • Park, B.-K., Zeng, X., Glazer, R. I. (2001). Akt1 Induces Extracellular Matrix Invasion and Matrix Metalloproteinase-2 Activity in Mouse Mammary Epithelial Cells. Cancer Res. 61: 7647-7653 [Abstract] [Full Text]  
  • Liu, H., Perlman, H., Pagliari, L. J., Pope, R. M. (2001). Constitutively Activated Akt-1 Is Vital for the Survival of Human Monocyte-Differentiated Macrophages: Role of Mcl-1, Independent of Nuclear Factor (Nf)-{kappa}b, Bad, or Caspase Activation. JEM 194: 113-126 [Abstract] [Full Text]  
  • Sevilla, L., Zaldumbide, A., Carlotti, F., Dayem, M. A., Pognonec, P., Boulukos, K. E. (2001). Bcl-xL Expression Correlates with Primary Macrophage Differentiation, Activation of Functional Competence, and Survival and Results from Synergistic Transcriptional Activation by Ets2 and PU.1. J. Biol. Chem. 276: 17800-17807 [Abstract] [Full Text]